MORRIS PLAINS, N.J., Oct. 18, 2007 (PRIME NEWSWIRE) -- Immunomedics, Inc. (NasdaqGM:IMMU - News), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that two posters will be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics from October 22-26, 2007 at the Moscone Convention Center in San Francisco, CA. The titles and abstract numbers of the presentations, together with the schedule and meeting places for the poster sessions are listed below:
